Geode Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-830,123
Closed -$23.8M 4190
2018
Q4
$23.8M Buy
830,123
+31,469
+4% +$894K 0.01% 1170
2018
Q3
$22.3M Sell
798,654
-1,889
-0.2% -$53.1K 0.01% 1337
2018
Q2
$22.3M Buy
800,543
+29,207
+4% +$783K 0.01% 1274
2018
Q1
$19.2M Buy
771,336
+21,092
+3% +$513K 0.01% 1295
2017
Q4
$18.2M Buy
750,244
+43,169
+6% +$1.14M 0.01% 1329
2017
Q3
$19.5M Buy
707,075
+91,924
+15% +$2.45M 0.01% 1257
2017
Q2
$15.4M Buy
615,151
+20,168
+3% +$499K 0.01% 1387
2017
Q1
$16M Buy
594,983
+31,314
+6% +$865K 0.01% 1321
2016
Q4
$14.8M Buy
563,669
+74,046
+15% +$1.83M 0.01% 1309
2016
Q3
$12.2M Buy
489,623
+28,243
+6% +$658K 0.01% 1366
2016
Q2
$10M Buy
461,380
+53,604
+13% +$956K 0.01% 1422
2016
Q1
$6.11K Buy
407,776
+14,354
+4% +$241K ﹤0.01% 1743
2015
Q4
$8.62M Buy
393,422
+2,647
+0.7% +$49.3K ﹤0.01% 1485
2015
Q3
$6.16M Buy
390,775
+16,629
+4% +$267K ﹤0.01% 1701
2015
Q2
$5.34M Buy
374,146
+23,360
+7% +$396K ﹤0.01% 1843
2015
Q1
$6.07M Buy
350,786
+19,362
+6% +$342K ﹤0.01% 1752
2014
Q4
$5.94M Buy
331,424
+6,617
+2% +$107K ﹤0.01% 1709
2014
Q3
$4.26M Buy
324,807
+16,604
+5% +$224K ﹤0.01% 1865
2014
Q2
$4.43M Buy
308,203
+3,864
+1% +$50.4K ﹤0.01% 1865
2014
Q1
$3.88M Buy
304,339
+27,296
+10% +$356K ﹤0.01% 1936
2013
Q4
$2.77M Buy
277,043
+26,869
+11% +$305K ﹤0.01% 2101
2013
Q3
$3.29M Buy
250,174
+19,242
+8% +$252K ﹤0.01% 1862
2013
Q2
$3.3M Buy
+230,932
New +$2.9M ﹤0.01% 1723

Other funds holding NXTM

Geode Capital Management's NXTM Position: Q1 2019 in Review

Geode Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 830,123 shares — an estimated $23.8M sold.

Geode Capital Management first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $23.8M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Geode Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Geode Capital Management sold 830,123 NxStage Medical Inc. shares in Q1 2019, an estimated $23.8M.
  • Geode Capital Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Geode Capital Management's NxStage Medical Inc. position peaked at $23.8M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Geode Capital Management's 13F filing for Q1 2019, filed 14 May 2019.